FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The U.S. Food and Drug Administration is requiring new safety warnings on all GLP-1 drugs after finding evidence of a potential increased risk of a rare eye condition, the agency said on Monday.
CNBC’s Annika Kim Constantino explains.
